C

Covetrus Inc
F:2NJ

Watchlist Manager
Covetrus Inc
F:2NJ
Watchlist
Price: 21.52 EUR 0.19%
Market Cap: €3B

Covetrus Inc
Net Issuance of Debt

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Covetrus Inc
Net Issuance of Debt Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Net Issuance of Debt CAGR 3Y CAGR 5Y CAGR 10Y
C
Covetrus Inc
F:2NJ
Net Issuance of Debt
-$624m
CAGR 3-Years
7%
CAGR 5-Years
1%
CAGR 10-Years
13%
Cardinal Health Inc
NYSE:CAH
Net Issuance of Debt
$1.2B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
-2%
Henry Schein Inc
NASDAQ:HSIC
Net Issuance of Debt
$553m
CAGR 3-Years
29%
CAGR 5-Years
N/A
CAGR 10-Years
21%
Patterson Companies Inc
NASDAQ:PDCO
Net Issuance of Debt
-$33.1m
CAGR 3-Years
23%
CAGR 5-Years
20%
CAGR 10-Years
13%
Mckesson Corp
NYSE:MCK
Net Issuance of Debt
-$1.6B
CAGR 3-Years
N/A
CAGR 5-Years
10%
CAGR 10-Years
-1%
Cencora Inc
NYSE:COR
Net Issuance of Debt
-$326.4m
CAGR 3-Years
29%
CAGR 5-Years
6%
CAGR 10-Years
N/A
No Stocks Found

Covetrus Inc
Glance View

Market Cap
3B EUR
Industry
Health Care

Nestled in the heart of the animal health industry, Covetrus Inc. emerged as a formidable force, blending technological expertise with deep-rooted veterinary knowledge. Created in 2019 through the merger of Henry Schein Animal Health and Vets First Choice, this company has swiftly positioned itself as an essential partner for veterinary practitioners. Covetrus provides a comprehensive suite of services designed to streamline operations for veterinary clinics, ranging from practice management software to inventory management systems. The core of their operation focuses on enhancing clinic efficiency and improving patient outcomes, driven by digital innovation that connects clinics effortlessly with critical pharmaceuticals, pet foods, and other essential products. Covetrus's business model thrives on a multi-pronged approach. Revenue streams flow widely from the robust sales of prescription and non-prescription medications, medical supplies, and pet products, underpinned by its vast, integrated distribution network. Moreover, the company's software solutions, which are integral to their service offering, generate additional income through subscription fees and service upgrades. This ability to cross-sell digital and physical products creates a cohesive ecosystem for veterinary professionals, ensuring that Covetrus not only meets day-to-day operational needs but also facilitates long-term growth and competitiveness for its customers. Their strategic positioning within the veterinary supply chain, coupled with a clear focus on enhancing clinical workflows, cements Covetrus's role as an indispensable ally in modern animal healthcare.

2NJ Intrinsic Value
Not Available
C

See Also

What is Covetrus Inc's Net Issuance of Debt?
Net Issuance of Debt
-624m USD

Based on the financial report for Dec 31, 2025, Covetrus Inc's Net Issuance of Debt amounts to -624m USD.

What is Covetrus Inc's Net Issuance of Debt growth rate?
Net Issuance of Debt CAGR 10Y
13%

Over the last year, the Net Issuance of Debt growth was 68%. The average annual Net Issuance of Debt growth rates for Covetrus Inc have been 7% over the past three years , 1% over the past five years , and 13% over the past ten years .

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett